GSK Spends $1B On Additional Stake In India Pharma Unit
GlaxoSmithKline PLC has bumped up its stake in its Indian pharmaceuticals subsidiary GlaxoSmithKline Pharmaceuticals Ltd., revealing Sunday that it spent 64 billion rupees ($1.05 billion) to increase its clout in a...To view the full article, register now.
Already a subscriber? Click here to view full article